
-
Markets rise as Trump chip exemptions boost tech giants
-
Japanese population sees record drop in 2024
-
United Airlines flights grounded in the US
-
Khachanov topples Zverev to reach ATP Toronto final
-
Mexican authorities accuse Adidas of cultural appropriation
-
World Cup host Morocco under pressure to save stray dogs
-
Trump's 'dividend' promise for Americans leaves open questions
-
Dangerous dreams: Inside internet's 'sleepmaxxing' craze
-
For Argentine farmers, Milei's free-market reforms fall short
-
Bank of England set to cut rate as UK economy weakens
-
Canadian teen Mboko beats Rybakina to reach WTA Montreal final
-
Ohtani homers for 1,000th MLB hit in Dodgers defeat
-
Trump hikes India levy over Russian oil as tariff deadline looms
-
Smiling through: Alcaraz won't let Wimbledon defeat get him down
-
Apple to invest additional $100 bn in US
-
Trump says likely to meet Putin 'very soon'
-
Major climate-GDP study under review after facing challenge
-
Lebanon's Hezbollah rejects cabinet decision to disarm it
-
Rare 'Hobbit' first edition auctioned for £43,000
-
Sinner lukewarm on expanded Cincinnati format
-
Rested Scheffler ready to tackle US PGA Tour playoffs
-
Sudan says army destroys Emirati aircraft, killing 40 mercenaries
-
White House says Trump open to meeting Putin and Zelensky
-
Grok, is that Gaza? AI image checks mislocate news photographs
-
'Global icon' Son Heung-min joins LAFC from Tottenham
-
In Cuba, Castro's 'influencer' grandson causes a stir
-
Mexican president backs threatened female football referee
-
France wildfire kills one as Spanish resort blaze 'stabilised'
-
German great Mueller signs with MLS Whitecaps
-
US government gets a year of ChatGPT Enterprise for $1
-
Trump calls Putin-Witkoff talks 'highly productive' but sanctions still due
-
Egypt sets opening of $1 bn Pyramids museum for Nov 1
-
Prince Harry, African charity row rumbles on as watchdog blames 'all parties'
-
Brazil seeks WTO relief against Trump tariffs
-
Isak told to train alone by Newcastle - reports
-
McDonald's sees US rebound but says low-income diners remain stressed
-
Trump hikes India levy over Russian oil as tariff deadline approaches
-
Swiss president hopes Washington talks avert surprise tariff
-
France wildfire kills one as Spanish resort evacuated
-
Stocks higher with eyes on earnings, US tariff deadline
-
Vonn appoints Svindal as coach ahead of 2026 Olympics
-
Backlash after 'interview' with AI avatar of US school shooting victim
-
Darth Vader's lightsaber could cost you an arm and a leg
-
Swiss president to meet Rubio as surprise tariff hike looms
-
Israel orders army to execute govt decisions on Gaza
-
Berlin wary as Berlusconi group closer to German media takeover
-
Italy approves plans for world's longest suspension bridge
-
Arsenal have 'belief' to end trophy drought, says Arteta
-
Putin decree allows Russia to increase greenhouse gas emissions
-
Putin holds 'constructive' talks with US envoy Witkoff ahead of sanctions deadline: Kremlin
SCU | 0% | 12.72 | $ | |
RBGPF | 1.42% | 76 | $ | |
CMSD | 0.13% | 23.54 | $ | |
RYCEF | 1.17% | 14.5 | $ | |
CMSC | -0.52% | 22.95 | $ | |
BCC | -4.64% | 82.92 | $ | |
RELX | -3.65% | 48.81 | $ | |
NGG | 0.03% | 72.3 | $ | |
SCS | 0.19% | 15.99 | $ | |
RIO | 0.65% | 60.09 | $ | |
GSK | -1.55% | 36.75 | $ | |
JRI | 0.6% | 13.34 | $ | |
BCE | -1.33% | 23.25 | $ | |
VOD | 1.77% | 11.3 | $ | |
BTI | 0.99% | 56.4 | $ | |
AZN | -1.2% | 73.6 | $ | |
BP | 0.83% | 33.88 | $ |

Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
T.Samara--SF-PST